| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Award | $0 | +3.58K | +9.04% | $0.00 | 43.2K | Mar 31, 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | -$23K | -1.23K | -2.84% | $18.80 | 41.9K | Mar 31, 2024 | Direct | |
| transaction | OGN | Common Stock | Award | $0 | +6.55K | +15.63% | $0.00 | 48.5K | Mar 31, 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | -$42.2K | -2.25K | -4.63% | $18.80 | 46.2K | Mar 31, 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -3.58K | -49.99% | $0.00 | 3.58K | Mar 31, 2024 | Common Stock | 3.58K | Direct | F1, F2 | |
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -6.55K | -33.33% | $0.00 | 13.1K | Mar 31, 2024 | Common Stock | 6.55K | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
| F2 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. |
| F3 | On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. |